Esperion Therapeutics, Inc. (ESPR): Price and Financial Metrics
ESPR Price/Volume Stats
| Current price | $2.19 | 52-week high | $3.94 |
| Prev. close | $2.17 | 52-week low | $1.58 |
| Day low | $2.12 | Volume | 6,141,700 |
| Day high | $2.23 | Avg. volume | 6,377,656 |
| 50-day MA | $2.41 | Dividend yield | N/A |
| 200-day MA | $2.24 | Market Cap | 431.51M |
ESPR Stock Price Chart Interactive Chart >
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
ESPR Price Returns
| 1-mo | -11.34% |
| 3-mo | 30.36% |
| 6-mo | 0.46% |
| 1-year | -7.20% |
| 3-year | -57.48% |
| 5-year | -96.07% |
| YTD | -26.76% |
| 2023 | -52.01% |
| 2022 | 24.60% |
| 2021 | -80.77% |
| 2020 | -56.40% |
| 2019 | 29.63% |
Continue Researching ESPR
Want to do more research on Esperion Therapeutics Inc's stock and its price? Try the links below:Esperion Therapeutics Inc (ESPR) Stock Price | Nasdaq
Esperion Therapeutics Inc (ESPR) Stock Quote, History and News - Yahoo Finance
Esperion Therapeutics Inc (ESPR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...